Angela Mastronuzzi

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

Francesca Del Bufalo, Biagio De Angelis, Ignazio Caruana et al. · New England Journal of Medicine · 2023 · 533 citations

Life Sciences, Immunology, Oncology +8

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

Matthew Clarke, Alan Mackay, Britta Ismer et al. · Cancer Discovery · 2020 · 278 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan

Maria Ester Bernardo, Eugenia Piras, Adriana Vacca et al. · Blood · 2012 · 195 citations

Medicine, Hematology, Stem Cell Transplantation +11

Modeling medulloblastoma in vivo and with human cerebellar organoids

Claudio Ballabio, Marica Anderle, Matteo Gianesello et al. · Nature Communications · 2020 · 175 citations · Full text

Medicine, Molecular Biology, Oncology +17

Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi et al. · Clinical Infectious Diseases · 2017 · 160 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17